2020 ICD-10-CM Diagnosis Code C94.00

Acute erythroid leukemia, not having achieved remission

    2016 2017 2018 2019 2020 Billable/Specific Code
  • C94.00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2020 edition of ICD-10-CM C94.00 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of C94.00 - other international versions of ICD-10 C94.00 may differ.
Applicable To
  • Acute erythroid leukemia with failed remission
  • Acute erythroid leukemia NOS
The following code(s) above C94.00 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C94.00:
  • C00-D49
    2020 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C81-C96
    2020 ICD-10-CM Range C81-C96

    Malignant neoplasms of lymphoid, hematopoietic and related tissue

    Type 2 Excludes
    • Kaposi's sarcoma of lymph nodes (C46.3)
    • secondary and unspecified neoplasm of lymph nodes (C77.-)
    • secondary neoplasm of bone marrow (C79.52)
    • secondary neoplasm of spleen (C78.89)
    Malignant neoplasms of lymphoid, hematopoietic and related tissue
  • C94
    ICD-10-CM Diagnosis Code C94

    Other leukemias of specified cell type

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • leukemic reticuloendotheliosis (C91.4-)
    • myelodysplastic syndromes (D46.-)
    • personal history of leukemia (Z85.6)
    • plasma cell leukemia (C90.1-)
    Other leukemias of specified cell type
  • C94.0
    ICD-10-CM Diagnosis Code C94.0

    Acute erythroid leukemia

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Applicable To
    • Acute myeloid leukemia M6(a)(b)
    • Erythroleukemia
    Acute erythroid leukemia
Approximate Synonyms
  • Acute erythroid leukemia
  • Erythroleukemia, fab m6
Clinical Information
  • A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
  • A progressive, proliferative disease of blood cells, originating from immature erythroid cells.
  • Acute erythroid leukemia characterised by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow.
  • Acute erythroid leukemia characterised by the presence of immature erythroid cells in the bone marrow (at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present.
  • An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. Severe anemia is a common symptom. This leukemia usually follows an aggressive clinical course. (who, 2001)
  • Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow.
  • Myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
  • The progression of a myelodysplastic syndrome in which there is erythroid predominance into erythroleukemia (m6a or erythroleukemia, erythroid/myeloid).
ICD-10-CM C94.00 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):
  • 820 Lymphoma and leukemia with major o.r. Procedure with mcc
  • 821 Lymphoma and leukemia with major o.r. Procedure with cc
  • 822 Lymphoma and leukemia with major o.r. Procedure without cc/mcc
  • 834 Acute leukemia without major o.r. Procedure with mcc
  • 835 Acute leukemia without major o.r. Procedure with cc
  • 836 Acute leukemia without major o.r. Procedure without cc/mcc
  • 837 Chemotherapy with acute leukemia as sdx or with high dose chemotherapy agent with mcc
  • 838 Chemotherapy with acute leukemia as sdx with cc or high dose chemotherapy agent
  • 839 Chemotherapy with acute leukemia as sdx without cc/mcc

Convert C94.00 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
ICD-10-CM Codes Adjacent To C94.00
C93.Z Other monocytic leukemia
C93.Z0 …… not having achieved remission
C93.Z1 …… in remission
C93.Z2 …… in relapse
C93.9 Monocytic leukemia, unspecified
C93.90 …… not having achieved remission
C93.91 …… in remission
C93.92 …… in relapse
C94 Other leukemias of specified cell type
C94.0 Acute erythroid leukemia
C94.00 …… not having achieved remission
C94.01 …… in remission
C94.02 …… in relapse
C94.2 Acute megakaryoblastic leukemia
C94.20 …… not having achieved remission
C94.21 …… in remission
C94.22 …… in relapse
C94.3 Mast cell leukemia
C94.30 …… not having achieved remission
C94.31 …… in remission
C94.32 …… in relapse

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.